Aegis Clinical Pharmacist, Andrew Holt, Pharm.D., BCMAS, CPGx, has released an op-ed where he expresses the importance of clinical definitive...
The Biden Administration recently designated the fentanyl-xylazine combination as an emerging national threat. Aegis Sciences Corporation in Nashville has been...
Aegis recent panelist, Alex J. Krotulski, PhD, released an op-ed that is an exploration into the identification of new and...
Aegis Clinical Pharmacist, Andrew Holt, Pharm.D., BCMAS, CPGx, has released an op-ed where he touches on Nashville's Drug Landscape, the...
NASHVILLE, Tenn. (Jan. 23, 2023) – Aegis Sciences Corporation, a health care testing lab based in Nashville, has published a Journal of...
Industry-leading testing offers insight into drug patterns and facilitates informed care Aegis Sciences Corporation, today announced the expansion of their proprietary, industry-leading...
Sign up for the Aegis Newsletter